AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminn M 4mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Made-inn Healthcare Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Gliminn M 4mg/500mg Tablet

Diabetic patients using Gliminn M 4mg/500mg tablets, a dual-action antidiabetic medication, should adhere to prescribed dosages. This combination therapy effectively manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake with meals maximizes efficacy; dosage adjustments are determined by your physician based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial to prevent complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, Gliminn M is only one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle changes are integral to effective diabetes control. Hypoglycemia (low blood sugar), a common side effect, manifests as sweating, dizziness, headache, or trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol should be avoided due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain is also possible. Gliminn M is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests assessing blood cell counts and liver function, is recommended.

Uses of Gliminn M 4mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gliminn M 4mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or breaking it. The Gliminn M 4mg/500mg Tablet should be taken with meals.

Common Side effects of Gliminn M 4mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminn M 4mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Gliminn M 4mg/500mg tablets should be administered with a meal.

How Gliminn M 4mg/500mg Tablet works:

Gliminn M 4mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliminn M 4mg/500mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminn M 4mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliminn M 4mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliminn M 4mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliminn M 4mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliminn M 4mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; the medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Gliminn M 4mg/500mg Tablet :

Should you forget to take your Gliminn M 4mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminn M 4mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Gliminn M 4mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminn M 4mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliminn M 4mg/500mg Tablets and seek immediate medical attention.
Gliminn M 4mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliminn M 4mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Gliminn M 4mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Gliminn M 4mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Gliminn M 4mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Gliminn M 4mg/500mg Table...
129
MRP 157
17% off